277 related articles for article (PubMed ID: 33748968)
1. Advancing drug discovery using the power of the human genome.
Heilbron K; Mozaffari SV; Vacic V; Yue P; Wang W; Shi J; Jubb AM; Pitts SJ; Wang X
J Pathol; 2021 Jul; 254(4):418-429. PubMed ID: 33748968
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in Pathology: the 2021 Annual Review Issue of The Journal of Pathology.
Herrington CS; Poulsom R; Koeppen H; Coates PJ
J Pathol; 2021 Jul; 254(4):303-306. PubMed ID: 34097314
[TBL] [Abstract][Full Text] [Related]
3. Advancing gastric cancer precision medicine with novel genomic screens
Halmai NB; Carvajal-Carmona LG
J Pathol; 2023 Apr; 259(4):359-361. PubMed ID: 36541926
[TBL] [Abstract][Full Text] [Related]
4. Validating and automating learning of cardiometabolic polygenic risk scores from direct-to-consumer genetic and phenotypic data: implications for scaling precision health research.
Lopez-Pineda A; Vernekar M; Moreno-Grau S; Rojas-Muñoz A; Moatamed B; Lee MTM; Nava-Aguilar MA; Gonzalez-Arroyo G; Numakura K; Matsuda Y; Ioannidis A; Katsanis N; Takano T; Bustamante CD
Hum Genomics; 2022 Sep; 16(1):37. PubMed ID: 36076307
[TBL] [Abstract][Full Text] [Related]
5. Beyond driver mutations: exploring the landscape of mutational signatures in adenocarcinomas of the bladder
Szarvas T; Reis H
J Pathol; 2024 Jun; ():. PubMed ID: 38847022
[TBL] [Abstract][Full Text] [Related]
6. Genetics meets pathology - an increasingly important relationship.
Bonthron DT; Foulkes WD
J Pathol; 2017 Jan; 241(2):119-122. PubMed ID: 27859271
[TBL] [Abstract][Full Text] [Related]
7. Ethical considerations for modern molecular pathology.
Vos S; van Diest PJ; Ausems MG; van Dijk MR; de Leng WW; Bredenoord AL
J Pathol; 2018 Dec; 246(4):405-414. PubMed ID: 30125358
[TBL] [Abstract][Full Text] [Related]
8. The genetics and pathology of mitochondrial disease.
Alston CL; Rocha MC; Lax NZ; Turnbull DM; Taylor RW
J Pathol; 2017 Jan; 241(2):236-250. PubMed ID: 27659608
[TBL] [Abstract][Full Text] [Related]
9. Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non-small cell lung cancer.
Alborelli I; Leonards K; Rothschild SI; Leuenberger LP; Savic Prince S; Mertz KD; Poechtrager S; Buess M; Zippelius A; Läubli H; Haegele J; Tolnay M; Bubendorf L; Quagliata L; Jermann P
J Pathol; 2020 Jan; 250(1):19-29. PubMed ID: 31471895
[TBL] [Abstract][Full Text] [Related]
10. Leveraging single-cell sequencing to unravel intratumour heterogeneity and tumour evolution in human cancers.
Bowes AL; Tarabichi M; Pillay N; Van Loo P
J Pathol; 2022 Jul; 257(4):466-478. PubMed ID: 35438189
[TBL] [Abstract][Full Text] [Related]
11. Unravelling the tumour genome: The evolutionary and clinical impacts of structural variants in tumourigenesis.
Hamdan A; Ewing A
J Pathol; 2022 Jul; 257(4):479-493. PubMed ID: 35355264
[TBL] [Abstract][Full Text] [Related]
12. In Brief: Myeloid-derived suppressor cells in cancer.
Solito S; Pinton L; Mandruzzato S
J Pathol; 2017 May; 242(1):7-9. PubMed ID: 28097660
[TBL] [Abstract][Full Text] [Related]
13. Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics.
Pulley JM; Shirey-Rice JK; Lavieri RR; Jerome RN; Zaleski NM; Aronoff DM; Bastarache L; Niu X; Holroyd KJ; Roden DM; Skaar EP; Niswender CM; Marnett LJ; Lindsley CW; Ekstrom LB; Bentley AR; Bernard GR; Hong CC; Denny JC
Assay Drug Dev Technol; 2017 Apr; 15(3):113-119. PubMed ID: 28379727
[TBL] [Abstract][Full Text] [Related]
14. The Role of Genetics in Advancing Cardiometabolic Drug Development.
Abou-Karam R; Cheng F; Gady S; Fahed AC
Curr Atheroscler Rep; 2024 May; 26(5):153-162. PubMed ID: 38451435
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo perfusion of human lymph nodes
Xu Q; Moore JE
J Pathol; 2020 Jul; 251(3):225-227. PubMed ID: 32356901
[TBL] [Abstract][Full Text] [Related]
16. The genetic background of inflammatory bowel disease: from correlation to causality.
Uniken Venema WT; Voskuil MD; Dijkstra G; Weersma RK; Festen EA
J Pathol; 2017 Jan; 241(2):146-158. PubMed ID: 27785786
[TBL] [Abstract][Full Text] [Related]
17. The genetics of mitochondrial disease: dissecting mitochondrial pathology using multi-omic pipelines.
Alston CL; Stenton SL; Hudson G; Prokisch H; Taylor RW
J Pathol; 2021 Jul; 254(4):430-442. PubMed ID: 33586140
[TBL] [Abstract][Full Text] [Related]
18. Established, emerging and elusive molecular targets in the treatment of lung cancer.
Gallant JN; Lovly CM
J Pathol; 2018 Apr; 244(5):565-577. PubMed ID: 29344953
[TBL] [Abstract][Full Text] [Related]
19. A genomics-based systems approach towards drug repositioning for rheumatoid arthritis.
Xu R; Wang Q
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):518. PubMed ID: 27557330
[TBL] [Abstract][Full Text] [Related]
20. Guidelines for clinical trials using artificial intelligence - SPIRIT-AI and CONSORT-AI
McGenity C; Treanor D
J Pathol; 2021 Jan; 253(1):14-16. PubMed ID: 33016344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
